BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, April 5, 2026
Home
»
Newsletters
» BioWorld
BioWorld
May 21, 2012
View Archived Issues
BioWorld Stock Report For Public Biotechnology Companies
Read More
Stock Gainers and Losers For The Week
Read More
Money Raised by Biotech Jan. 1 - May 18, 2012
Read More
Money Raised by Biotech 2012 Vs. 2011
Read More
Biotech-Biotech Collaborations: Modified And Terminated Agreements: April 1 - May 18, 2012
Read More
Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: April 1 - May 18, 2012
Read More
Biotechnology Company Deals With Other Biotechnology Companies: April 1 - May 18, 2012
Read More
Top Deals Between Biotech Companies: 2012
Read More
Investment Practice Changes By LPs Could Help Startups
The Ewing Marion Kauffman Foundation issued a report this month blaming the lackluster returns from venture capital on a lack of oversight from limited partners (LPs) that invest in the funds.
Read More
Novartis Expands R&D as Other Pharmas Cut Back
At a time when many big pharmas are trimming internal research programs, Novartis AG has been quietly expanding.
Read More
Week in Review
Read More
Word on the Street
Read More
Week in Washington
Read More
